Genetic Biomarker May Predict Severity of Food Allergy
Researchers reported for the first time that a genetic biomarker may be able to help predict the severity of food allergy reactions.
Researchers reported for the first time that a genetic biomarker may be able to help predict the severity of food allergy reactions.
Sebia has announced the acquisition of Zeus Scientific, an In Vitro Diagnostic (IVD) company based in New Jersey.
The CDC launched a new report offering up-to-date county-level maps of seven different disease-causing germs or pathogens cause by ticks.
Antiphospholipid syndrome in children is often not identified until destructive clotting has already occurred.
Read MoreResearchers have developed a novel test that simplifies the allergy diagnosis and can reliably predict the success of a therapy.
Read MoreA new testing mechanism for Lyme disease can better identify the disease sooner, show when people are cured, and diagnose reinfection.
Read MoreEarly detection of tick-borne diseases can be tricky, but increased awareness and better diagnostics can help reduce false negatives.
Read MoreThe findings suggest that following current guidelines may lead to over-diagnoses in infants by labeling normal infant symptoms as possible milk allergies.
Read MoreCells from a cheek swab revealed biomarkers for rheumatoid arthritis that could lead to a way to diagnose and begin treatment before the disease develops.
Read MorePenicillin allergy testing during pregnancy may help avoid infant illness from infection, according to a new study from the ACAAI.
Read MoreThermo Scientific EliA SmDP-S test has been cleared by the FDA for aiding the diagnosis of SLE, the most common type of lupus.
Read MoreThere are an array of non-invasive serological tests that are highly accurate and can help cut the time to celiac disease diagnosis.
Read MoreResearchers from Ikerbasque and the UPV/EHU have developed a non-invasive method to help diagnose celiac disease using saliva.
Read MoreScientists have trained an artificial intelligence system to recognize a specific pattern in skin biopsies of patients with the blistering disease epidermolysis bullosa acquisita.
Read MoreFind out how serology can aid in the diagnosis of this autoimmune disease during the pandemic, instead of biopsy.
Read MoreAutomation using Nova View and the Nova Lite DAPI dsDNA Crithidia luciliae Kit can significantly improve laboratory turnaround time and reduce technician hands-on time.
Read MoreATCC joins the National Institute of Allergy and Infectious Diseases’ team working on preclinical services for HIV therapeutics.
Read MoreThese are the first proteomic data allowing a differential analysis of four different inflammatory rheumatic diseases.
Read More